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Résumé en
anglais
BACKGROUND: The hepatitis C virus (HCV) RNA-dependent RNA polymerase,
NS5B, is essential for virus RNA replication. It is thus an attractive therapeutic
target. Several compound nucleoside analogues, non-nucleoside inhibitors and
cyclosporine analogues are being developed to inhibit NS5B activity. However,
nucleotide changes in the NS5B gene can confer resistance to them.METHODS: We
investigated the prevalence of known substitutions conferring resistance in HCV
polymerase in 124 treatment-naive French patients infected with HCV genotypes 1,
2, 3, 4 or 5 by sequencing the NS5B gene. RESULTS: None of the 124 HCV NS5B
sequences analysed contained substitutions conferring resistance to nucleoside
analogues; however, NS5B polymerases containing substitutions conferring
resistance to non-nucleoside inhibitors were frequent within genotype 1 strains
(17%) and very common in non-genotype 1 strains. Similarly, substitutions
conferring resistance to cyclosporine analogues were more prevalent within the
various genotypes. CONCLUSIONS: Naturally occurring substitutions conferring
resistance to NS5B inhibitors are common in treatment-naive patients infected with
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